GLIFLOEAST M

Dapagliflozin and Metformin are commonly used together to manage type 2 diabetes.

• Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by promoting glucose excretion through urine. It also aids in weight loss and reduces the risk of cardiovascular complications.

• Metformin is a first-line biguanide medication that decreases glucose production in the liver, improves insulin sensitivity, and enhances glucose uptake by muscles.

Together, they provide an effective approach to controlling blood sugar levels, improving overall glycemic control, and reducing diabetes-related complications.